|Closing date for invited submissions / evidence submission:||TBC|
|1st appraisal committee meeting:||TBC|
|2nd appraisal committee meeting:||TBC|
|29 March 2011||
The treatment of chronic hepatitis B in adults with cirrhosis, including those with liver decompensation is included in the scope of the Clinical Guideline Hepatitis B (chronic): diagnosis and management of chronic hepatitis B in children, young people and adults.
Therefore, the appraisal of entecavir and tenofovir disoproxil fumarate for the treatment of chronic hepatitis B in adults with decompensated liver disease has been un-referred from the NICE technology appraisal work programme.
|8 March 2011||
Following the additional draft scope consultation, further discussions with the Department of Health and noting the overlap between the Technology Appraisal and the recently referred Clinical Guideline; The diagnosis and management of hepatitis B in children, adolescents and adults, it has been decided that the Technology Appraisal will be suspended until the outcome of the scoping process for the Clinical Guideline is known.
|6 May 2010||
Please note that this appraisal is now expected to start inapproximately early December 2010.
The deadline for submissions is expectedin approximately late March 2011.
For further information on how we develop guidance, please see our page about NICE technology appraisal guidance